Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory.
Autorzy:
Podlekareva DN; CHIP, Rigshospitalet, University of Copenhagen, Denmark. Folkvardsen DB; International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark. Skrahina A; Republican Scientific and Practical Center for Pulmonology and TB, Minsk, Belarus. Vassilenko A; Belarusian State Medical University, Minsk, Belarus. Skrahin A; Republican Scientific and Practical Center for Pulmonology and TB, Minsk, Belarus.; Belarusian State Medical University, Minsk, Belarus. HurevichH; Republican Scientific and Practical Center for Pulmonology and TB, Minsk, Belarus. Klimuk D; Republican Scientific and Practical Center for Pulmonology and TB, Minsk, Belarus. Karpov I; Belarusian State Medical University, Minsk, Belarus. Lundgren JD; CHIP, Rigshospitalet, University of Copenhagen, Denmark. Kirk O; CHIP, Rigshospitalet, University of Copenhagen, Denmark.; Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Denmark. Lillebaek T; International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.; Global Health Section, Department of Public Health, University of Copenhagen, Denmark.
Pokaż więcej
Źródło:
Tuberculosis research and treatment [Tuberc Res Treat] 2021 Apr 02; Vol. 2021, pp. 6646239. Date of Electronic Publication: 2021 Apr 02 (Print Publication: 2021).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
